| 22900 | NARCAG | Narcolepsy Associated Antigen (NARC) | Narcolepsy Associated Ag, B | | | 26322 | NASCOV | Nasal COVID 19 Nucleic Acid Test (NAT) PCR | COVID 19 PCR, SARS-CoV-2, Coronavirus | | | 23294 | NASHSO | NASH FibroSURE (550140) | Fatty Liver Disease, NAFLD, Nonalcoholic Fatty Liver Disease, Noninvasive Liver Biopsy, Steatohepatitis | a2-macroglobulin, haptoglobin, apolipoprotein A1, bilirubin, y-glutamyl transpeptidase (GGT), alanine aminotransferase (ALT), aspartate aminotransferase (AST), total cholesterol, triglycerides, and fasting glucose | | 25063 | NK | Natural Killer (CD16, CD56, CD57) Profile | Flow Cytometry
| | | 23232 | | Natural Killer Cells | Flow Cytometry, Killer Cells | | | 26464 | MGRNASO | Neisseria gonorrhoeae, Miscellaneous Sites, Nucleic Acid Amplification, Varies (MGRNA) | Neisseria gonorrhoeae RNA amplification Gonorrhoeae Gonorrhea Neisseria gonorrhoeae RNA Probe | | | 26523 | GCRNASO | Neisseria gonorrhoeae, Nucleic Acid Amplification, Varies (GCRNA) | GC RNA Probe
RNA Probe Chlam/Neis STD Panel Gonorrhoeae RNA Probe Gonorrhea
| | | 22901 | GC-NAM | Neisseria Gonorrhoeae, Nucleic Acid Method (NAM) | Neisseria gonorrhoea, Gonorrhea, GC
| | | 25223 | NEO | Neonatal Screen (281) | PKU-Newborn Screening, CAH Trypsinogen Screen, Newborn Screening | | | 24742 | BBNBSCN | Neonate Transfusion | Neonate type and screen, Newborn type and screen, Newborn transfusion, Quad pack, BBNBSCN, Newborn Type & AbScn & DAT | ABO/RH, DAT, ABSC, may include Weak D. | | 25597 | NMOFSSO | Neuromyelitis Optica (NMO)/Aquaporin-4-IgG Fluorescence-Activated Cell Sorting (FACS) Assay, Serum (NMOFS) | AQP, AQP4, Aquaporin, Devic's Antibody, NMO (Neruomyelitis Optica), NMO-IgG, Optic Neuritis Antibody, Transverse Myelitis Antibody, Vision Loss Antibody33 | When the results of this assay require further evaluation, NMOTS/Neuromyelitis Optica (NMO)/Auaporin-4-IgG Fluorescence-Activated Cell Sorting (FACS) Titer Assay, Serum will be performed at an additional charge. | | 22904 | NSESO | Neuron-Specific Enolase (NSE) | NSE Enolase
| | | 26294 | NONCPSO | Neuro-Oncology Expanded Gene Panel with Rearrangement, Tumor (NONCP) | ATRX, BRAF, Brain tumor, Central nervous system (CNS) cancers, EGFR, H3F3A, HIST1H3B, HIST1H3C, IDH1, IDH2, Next Gen Sequencing Test, NGS, Oncology panel, RELA, SMARCA4, SMARB1, TERT, H3-3A, H3C2, H3C3, MSI, Microsatellite Instability
NeuroOnc Exp GenPa Tum (NONCP) TI NONCPSO | | | 25045 | NICTS | Nicotine and Metabolites, Serum | Cotinine, Nicotine Metabolite, 3-OH-cotinine, trans-3-hydroxycotinine, trans-3-OH-cotinine | | | 26128 | NICOSSO | Nicotine and Metabolites, Serum (NICOS) | Cotinine, Tobacco Alkaloids | Nicotine, Cotinine | | 26296 | CO-NICT | Nicotine and Metabolites, Urine Confirm only by LCMSMS | | This is a quantitative urine test utilizing Liquid Chromatography/Tandem Mass Spectrometry (LCMS/MS) using Multiple Reaction Monitoring to determine presence and concentration of nicotine and cotinine. | | 25594 | NMDARSO | N-methyl-D-Aspartate Receptor Antibody, IgG, CSF with Reflex to Titer (2005164) | anti-GluN1, Anti-NMDA CSF, anti-NR1, Glutamate Receptor Antibodies, N-Methyl D-Aspartate Ab CSF, NMDA R, NMDA Receptor Ab CSF | | | 26197 | NMH24SO | N-Methylhistamine, 24 hr U (NMH24) | 1-Methylhistamine
Histamine Metabolites
Urinary N-Methylhistamine N-Methylhist. 24 Hr U (NMH24) N-Methylhistamine, 24 Hour, Urine 24 NM24SO | N-Methylhistamine, 24 Hr, U Creatinine, 24 Hr, U | | 26198 | NMHRSO | N-Methylhistamine, Urine (NMHR) | 1-Methylhistamine
Histamine Metabolites
Urinary N-Methylhistamine NMHR NMH N-Methylhistamine N-Methylhistamine, Random, Urine N-Methylhist. Rand, U (NMHR) U NMHRSO | N-Methylhistamine, Random Creatinine, Random, U | | 24994 | NMOESO | NMO/AQP4-IgG Cell Binding Assay (NMOCS) | AQP, AQP4, Aquaporin, Devic's Antibody, NMO (Neuromyelitis Optica), NMO-IgG, Optic Neuritis Antibody, Transverse Myelitis Antibody, Vision Loss Antibody | | | 23145 | NMRLISO | NMR Lipoprotein Quant 123638 | NMR, Small dense LDL, HDL-C | Color graphical report; historical reporting (LDL-P, LDL-C); insulin resistance and diabetes risk markers (large VLDL-P, small LDL-P, large HDL-P, VLDL size, LDL size, HDL size); insulin-resistance score; lipoprotein particle number (LDL-P); particle concentration and size (total HDL-P, small LDL-P, LDL size); standard lipid panel (total cholesterol, calculated LDL cholesterol, HDL cholesterol, triglycerides). | | 26133 | LNOROSO | Norovirus PCR, Molecular Detection, Feces (LNORO) | Norwalk virus Norovirus PCR, Feces ST LNOROSO | Norovirus G1 Norovirus G2 | | 22906 | NORTSO | Nortriptyline (NOTRP) | Aventyl (Nortriptyline), Serum, Nortriptyline, Serum, Pamelor (Nortriptyline), Serum, Sensoval, Aventyl, Pamelor, Norpress, Allegron, and Nortrilen (Nortriptyline), TCA (Tricyclic Antidepressants), Tricyclic Antidepressants (TCA) | | | 25075 | NPMCBSO | NPM1 Mutation with CEBPA Analysis if Needed (4637) | Ref Lab Code: 4637 | | | 23225 | NTXBSO | N-terminal Telopeptide, Serum (SNTX) | Collagen Crosslinks; Crosslinked N-telopeptide of Type I Collagen (NTX), Serum; N-Telopeptide, Serum; NTX; Osteomark; Osteoporosis; N-Telopeptide X-Link, Serum | N-Terminal Telolpeptide | | 22907 | NTXSO | NTX-Telopeptide, Urine (NTXPR) | Collagen Crosslinks
Crosslinked N-telopeptide of Type I Collagen (NTX), Urine
N-Telopeptide, Urine
NTX Creatinine
Osteomark
Osteoporosis NTXPR U NTXSO | |
|